BrightAccountsProduction v1.0.0 v1.0.0 2024-05-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts FRS 105 Accounts The principal activity of the company is that of consulting within the pharmaceutical industry. 27 October 2025 0 0 NI696235 2025-04-30 NI696235 2024-04-30 NI696235 2023-04-30 NI696235 2024-05-01 2025-04-30 NI696235 2023-05-01 2024-04-30 NI696235 uk-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 NI696235 uk-curr:PoundSterling 2024-05-01 2025-04-30 NI696235 uk-bus:AbridgedAccounts 2024-05-01 2025-04-30 NI696235 uk-core:CapitalReserve 2025-04-30 NI696235 uk-core:CapitalReserve 2024-04-30 NI696235 2024-05-01 2025-04-30 NI696235 uk-bus:Director1 2024-05-01 2025-04-30 NI696235 uk-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 NI696235 uk-bus:Micro-entities 2024-05-01 2025-04-30 xbrli:pure iso4217:GBP xbrli:shares

E Shields Consulting Ltd

Unaudited Financial Statements

for the financial year ended 30 April 2025

E Shields Consulting Ltd

Company Registration Number: NI696235

BALANCE SHEET

as at 30 April 2025

|  | 2025 |  | 2024
|  | £ |  | £
| Fixed Assets | 1,566 |  | 516
|  | ───────── |  | ─────────
| Current assets | 8,658 |  | 6,073
| Creditors: amounts falling due within one year | (1,237) |  | (2,743)
|  | ───────── |  | ─────────
| Net Current Assets | 7,421 |  | 3,330
|  | ───────── |  | ─────────
| Total Assets less Current Liabilities | 8,987 |  | 3,846
| Accruals and deferred income | (500) |  | (500)
|  | ───────── |  | ─────────
| Net Assets | 8,487 |  | 3,346
|  | ═════════ |  | ═════════
| Capital and Reserves | 8,487 |  | 3,346
|  | ═════════ |  | ═════════
| Notes to the Financial statements

1. | General Information
| E Shields Consulting Ltd is a private company limited by shares, incorporated and registered in Northern Ireland. The registered number of the company is NI696235. The registered office of the company is 43 Warrenpoint Road, Newry, Co. Down, BT34 2PN, Northern Ireland which is also the principal place of business of the company The financial statements have been presented in Pound Sterling (£) which is the functional currency of the company. The financial statements represent the individual entity for the year ended 30 April 2025. The comparative period represents the individual entity from the date of incorporation; 12 April 2023 to 30 April 2024, and as such, the comparatives are not entirely comparable.

2. | Employees
| The company did not engage any employees in the financial period, or the comparative period.

3. | Director's advances, credits and guarantees
| During the financial year ended 30th April 2025 the director was in receipt of a loan totalling £3,542. This was repaid in full within 9 months of the financial year end. No interest was charged on the loan, and it was repayable on demand.

| For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
| The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
| The director acknowledges her responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
| These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
| The company has taken advantage of the exemption under section 444 not to file the Director's Report, Abridged Profit and Loss Account.
| Approved by the Director on 27 October 2025 and signed by:
| ________________________________ |
| Ennis Shields |
| Director |